Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2016Clinical Cancer Research

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

View Full Paper
Ask AI
Bookmark
Share

Authors

YMYumeng MaoNENina EißlerKBKatarina Le Blanc

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mao et al. (2016) studied this question.

synapsesocial.com/papers/6a884a03ceefe68dba4fccb2https://doi.org/10.1158/1078-0432.ccr-15-1912
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response2007 · 845 citations
  2. 2Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells2013 · 261 citations